Beyond the traditional prognostic indicators: The impact of primary care utilization on cancer survival

Journal of Clinical Oncology

Volumn 25, Issue 36, 2007, Pages 5793-5799

  Jones, Laura E ^a   Doebbeling, Caroline Carney ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; COMORBIDITY; DISEASE ASSOCIATION; FOLLOW UP; HEALTH CARE UTILIZATION; HUMAN; LUNG CANCER; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 37649019453     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.13.6127     Document Type: Article

References (55)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2007. CA Cancer J Clin 57:43-66, 2007
2. Kutikova L, Bowman L, Chang S, et al: The economic burden of lung cancer and the associated costs of treatment failure in the United States. Lung Cancer 50:143-154, 2005
3. Wang SJ, Fuller CD, Thomas CR Jr: Ethnic disparities in conditional survival of patients with non-small-cell lung cancer. J Thorac Oncol 2:180-190, 2007
4. Jazieh AR, Kyasa MJ, Sethuraman G, et al: Disparities in surgical resection of early-stage non-small-cell lung cancer. J Thorac Cardiovasc Surg 123:1173-1176, 2002
5. Bach PB, Cramer LD, Warren JL, et al: Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341:1198-1205, 1999
6. National Cancer Institute: Cancer Query Systems: SEER Survival Statistics. Bethesda, MD, National Cancer Institute, 2007
7. Clegg LX, Li FP, Hankey BF, et al: Cancer survival among US whites and minorities: A SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med 162:1985-1993, 2002
8. Skuladottir H, Olsen JH: Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 21:3035-3040, 2003
9. Tammemagi CM, Neslund-Dudas C, Simoff M, et al: In patients with lung cancer, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol 57:597-609, 2004
10. Janssen-Heijnen ML, Lemmens VE, van den Borne BE, et al: Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: A population-based study in the Netherlands. Crit Rev Oncol Hematol 62:172-178, 2007
11. Tammemagi CM, Neslund-Dudas C, Simoff M, et al: Impact of comorbidity on lung cancer survival. Int J Cancer 103:792-802, 2003
12. Battafarano RJ, Piccirillo JF, Meyers BF, et al: Impact of comorbidity on survival after surgical resection in patients with stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 123:280-287, 2002
13. Gonlugur TE, Gonlugur U: Comorbidity as a prognostic factor in small-cell lung cancer. Tumori 92:423-428, 2006
14. Birim O, Kappetein AP, Bogers AJ: Charlson comorbidity index as a predictor of long-term outcome after surgery for non-small-cell lung cancer. Eur J Cardiothorac Surg 28:759-762, 2005
15. Kurtz ME, Kurtz JC, Given CW, et al: Predictors of use of health care services among elderly patients with lung cancer: The first year after diagnosis. Support Care Cancer 14:243-250, 2006
16. Ko C, Chaudhry S: The need for a multidisciplinary approach to cancer care. J Surg Res 105:53-57, 2002
17. Kurtz ME, Kurtz JC, Given CW, et al: Utilization of services among elderly cancer patients: Relationship to age, symptoms, physical functioning, comorbidity, and survival status. Ethn Dis 15:S17-22, 2005
18. Earle CC: Influenza vaccination in elderly patients with advanced colorectal cancer. J Clin Oncol 21:1161-1166, 2003
19. Tammemagi CM, Neslund-Dudas C, Simoff M, et al: Smoking and lung cancer survival: The role of comorbidity and treatment. Chest 125:27-37, 2004
20. Grossman E, Messerli FH, Boyko V, et al: Is there an association between hypertension and cancer mortality? Am J Med 112:479-486, 2002
21. Lee SY, Kim MT, Jee SH, et al: Does hypertension increase mortality risk from lung cancer? A prospective cohort study on smoking, hypertension and lung cancer risk among Korean men. J Hypertens 20:617-622, 2002
22. Peeters PH, van Noord PA, Hoes AW, et al: Hypertension, antihypertensive drugs, and mortality from cancer among women. J Hypertens 16:941-947, 1998
23. Mukamel DB, Bajorska A, Temkin-Greener H: Health care services utilization at the end of life in a managed care program integrating acute and long-term care. Med Care 40:1136-1148, 2002
24. Veterans Health Administration.FY2004 VHA Performance Measurement System Technical Manual. Washington, DC, Veterans Health Administration, 2004
25. Rabeneck L, Davila JA, Thompson M, et al: Outcomes in elderly patients after surgery for colorectal cancer in the veterans affairs health care system. Aliment Pharmacol Ther 20:1115-1124, 2004
26. Rabeneck L, Souchek J, El-Serag HB: Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol 98:1186-1192, 2003
27. Freeman VL, Durazo-Arvizu R, Arozullah AM, et al: Determinants of mortality after a diagnosis of prostate cancer in Veterans Affairs and private sector health care systems. Am J Public Health 93:1706-1712, 2003
28. Dominitz JA, Maynard C, Billingsley KG, et al: Race, treatment, and survival of veterans with cancer of the distal esophagus and gastric cardia. Med Care 40:I14-26, 2002 (suppl)
29. Sohn MW, Arnold N, Maynard C, et al: Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr 4:2, 2006
30. Page WF, Mahan CM, Kang HK: Vital status ascertainment through the files of the Department of Veterans Affairs and the Social Security Administration. Ann Epidemiol 6:102-109, 1996
31. Elixhauser A, Steiner C, Harris DR, et al: Comorbidity measures for use with administrative data. Med Care 36:8-27, 1998
32. Selim AJ, Fincke G, Ren XS, et al: Comorbidity assessments based on patient report: Results from the Veterans Health Study. J Ambul Care Manage 27:281-295, 2004
33. Klabunde CN, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000
34. Ball JK, Elixhauser A: Treatment differences between blacks and whites with colorectal cancer. Med Care 34:970-984, 1996
35. Davila JA, Rabeneck L, Berger DH, et al: Postoperative 30-day mortality after surgical resection for colorectal cancer in veterans: Changes in the right direction. Dig Dis Sci 50:1722-1728, 2005
36. Paramore LC, Thomas SK, Knopf KB, et al: Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer. Clin Colorectal Cancer 6:52-58, 2006
37. Ogle KS, Swanson GM, Woods N, et al: Cancer and comorbidity: Redefining chronic diseases. Cancer 88:653-663, 2000
38. Firat S, Bousamra M, Gore E, et al: Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52:1047-1057, 2002
39. Firat S, Byhardt RW, Gore E: Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: An institutional analysis of patients treated on four RTOG studies - Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 54:357-364, 2002
40. Birim O, Kappetein AP, Goorden T, et al: Proper treatment selection may improve survival in patients with clinical early-stage non-small-cell lung cancer. Ann Thorac Surg 80:1021-1026, 2005
41. Brouchet L, Bauvin E, Marcheix B, et al: Impact of induction treatment on postoperative complications in the treatment of non-small-cell lung cancer. J Thorac Oncol 2:626-631, 2007
42. de Rijke JM, Schouten LJ, ten Velde GP, et al: Influence of age, comorbidity, and performance status on the choice of treatment for patients with non-small cell lung cancer: Results of a population-based study. Lung Cancer 46:233-245, 2004
43. Klabunde CN, Legler JM, Warren JL, et al: A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and patients with lung cancer. Ann Epidemiol 17:584-590, 2007
44. Pavia R, Spinelli F, Monaco M, et al: Lung cancer and cardiovascular diseases: Occurrence, comorbidity and surgical timing. J Cardiovasc Surg (Torino) 48:227-231, 2007
45. Chen M, Jiang GL, Fu XL, et al: The impact of overall treatment time on outcomes in radiation therapy for non-small-cell lung cancer. Lung Cancer 28:11-19, 2000
46. Jeremic B, Shibamoto Y, Milicic B, et al: Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone. Lung Cancer 40:317-323, 2003
47. Efficace F, Bottomley A, Smit EF, et al: Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell patients with lung cancer? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol 17:1698-1704, 2006
48. Yang P, Allen MS, Aubry MC, et al: Clinical features of 5,628 primary patients with lung cancer: Experience at Mayo Clinic from 1997 to 2003. Chest 128:452-462, 2005
49. Conron M, Phuah S, Steinfort D, et al: Analysis of multidisciplinary lung cancer practice. Intern Med J 37:18-25, 2007
50. Baser S, Shannon VR, Eapen GA, et al: Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest 130:1784-1790, 2006
51. Videtic GM, Stitt LW, Dar AR, et al: Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 21:1544-1549, 2003
52. Fox JL, Rosenzweig KE, Ostroff JS: The effect of smoking status on survival after radiation therapy for non-small-cell lung cancer. Lung Cancer 44:287-293, 2004
53. United States Department of Veterans Affairs: Search VACCR. http://www1.va.gov/cancer/page.cfm?pg=17
54. Borowsky SJ, Cowper DC: Dual use of VA and non-VA primary care. J Gen Intern Med 14:274-280, 1999
55. Hewitt M, Simone JV Ensuring Quality Cancer Care. Washington, DC, National Academy Press, 1999